Faculty of Medical Sciences, Department of Gastroenterology, Pulido Valente Hospital, Lisbon, Portugal.
Surg Endosc. 2013 Jan;27(1):313-24. doi: 10.1007/s00464-012-2368-3. Epub 2012 Jul 18.
Fully covered self-expandable metal stents (FCSEMS) have been used as a rescue therapy for several benign biliary tract conditions (BBC). Long-term stent placement commonly occurs, and prolonged FCSEMS placement is associated with the majority of the complications reported. This study evaluated the duration of stenting and the efficacy and safety of temporary FCSEMS placement for three BBCs: refractory biliary leaks, postsphincterotomy bleeding, and perforations.
This was a retrospective case series with long-term follow-up of 25 patients who underwent FCSEMS placement for BBCs. This study included 17 patients with postcholecystectomy refractory biliary leaks who had previously undergone unsuccessful sphincterotomy and plastic stent placement, 4 patients with difficult-to-control postsphincterotomy bleeding, and 4 patients with a perforation following endoscopic sphincterotomy. Stents were removed according to clinical evidence of problem resolution. The review included stenting duration, safe FCSEMS removal, clinical efficacy, complications, and long-term outcomes. During the follow-up period, ERCP and cholangioscopy procedures were performed to exclude the possibility of bile duct lesion development.
Complete resolution of the initial condition was achieved in all patients. Patients with biliary leaks had a median stent duration time of 16 days (range 7-28 days). Patients with bleeding had stents removed after a median time of 6 days (range 3-15 days). Patients with perforations had their stents removed after a median time of 29.5 days (range 21-30 days). There were no complications related to stenting.
Temporary placement of a FCSEMS for 30 days or less is an effective rescue therapy for refractory biliary leaks, difficult-to-control post-endoscopic sphincterotomy bleeding, and perforations. Duration of stenting should be different for each type of condition. Stents can be safely removed, and short-term stenting is associated with the absence of early and late complications.
全覆膜自膨式金属支架(FCSEMS)已被用作多种良性胆道疾病(BBC)的抢救治疗方法。支架长期留置很常见,而 FCSEMS 留置时间延长与大多数报告的并发症有关。本研究评估了三种 BBC(难治性胆漏、内镜下括约肌切开术后出血和穿孔)中支架留置时间、临时 FCSEMS 放置的疗效和安全性。
这是一项回顾性病例系列研究,对 25 例行 FCSEMS 治疗 BBC 的患者进行了长期随访。本研究包括 17 例经胆囊切除术后难治性胆漏患者,这些患者先前已行不成功的括约肌切开术和塑料支架置入术,4 例难以控制的内镜下括约肌切开术后出血患者,以及 4 例内镜下括约肌切开术后穿孔患者。根据临床问题解决的证据取出支架。回顾内容包括支架留置时间、安全取出 FCSEMS、临床疗效、并发症和长期结果。在随访期间,行 ERCP 和胆管镜检查以排除胆管损伤发展的可能性。
所有患者的初始情况均完全缓解。胆漏患者的中位支架留置时间为 16 天(范围 7-28 天)。出血患者的支架在中位时间 6 天后取出(范围 3-15 天)。穿孔患者的支架在中位时间 29.5 天后取出(范围 21-30 天)。无与支架相关的并发症。
对于难治性胆漏、内镜下括约肌切开术后难以控制的出血和穿孔,临时放置 FCSEMS 30 天或更短时间是一种有效的抢救治疗方法。每种类型的疾病留置时间应不同。支架可以安全取出,短期支架留置与早期和晚期并发症无关。